AFVZX
Price
$22.72
Change
-$0.14 (-0.61%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

AFVZX vs RMFCX

Header iconAFVZX vs RMFCX Comparison
Open Charts AFVZX vs RMFCXBanner chart's image
Applied Finance Select Institutional
Price$22.72
Change-$0.14 (-0.61%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
AFVZX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFVZX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFVZX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. AFVZX (558M). RMFCX pays higher dividends than AFVZX: RMFCX (1.69) vs AFVZX (1.02). AFVZX was incepted earlier than RMFCX: AFVZX (8 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. AFVZX (11.26). RMFCX has a lower initial minimum investment than AFVZX: RMFCX (250) vs AFVZX (10000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. AFVZX (10.56). AFVZX return over 5 years is better than : 67.59 vs. RMFCX (40.39).
AFVZXRMFCXAFVZX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD8.91711.42378%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets558M104B1%
Annual Yield % from dividends1.021.6960%
Returns for 1 year10.5612.6384%
Returns for 3 years17.3314.16122%
Returns for 5 years67.5940.39167%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc